These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 29926766)
1. Performance-Enhancing Drugs Abuse Caused Cardiomyopathy and Acute Hepatic Injury in a Young Bodybuilder. Li C; Adhikari BK; Gao L; Zhang S; Liu Q; Wang Y; Sun J Am J Mens Health; 2018 Sep; 12(5):1700-1704. PubMed ID: 29926766 [TBL] [Abstract][Full Text] [Related]
2. Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids. Clark BM; Schofield RS Pharmacotherapy; 2005 May; 25(5):756-61. PubMed ID: 15899737 [TBL] [Abstract][Full Text] [Related]
3. Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder. Bispo M; Valente A; Maldonado R; Palma R; Glória H; Nóbrega J; Alexandrino P World J Gastroenterol; 2009 Jun; 15(23):2920-2. PubMed ID: 19533818 [TBL] [Abstract][Full Text] [Related]
4. Anabolics and cardiomyopathy in a bodybuilder: case report and literature review. Ahlgrim C; Guglin M J Card Fail; 2009 Aug; 15(6):496-500. PubMed ID: 19643360 [TBL] [Abstract][Full Text] [Related]
5. Polycythemia and renal infarction in a bodybuilder. Ammatuna E; Nijziel MR QJM; 2014 Aug; 107(8):661-2. PubMed ID: 24557731 [No Abstract] [Full Text] [Related]
6. Spontaneous hepatic rupture in a bodybuilder: a case report and review of the literature. Mascagni P; Melandro F; Larghi Laureiro Z; Mennini G; Rossi M Rev Esp Enferm Dig; 2018 Apr; 110(4):254-256. PubMed ID: 29313696 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280 [TBL] [Abstract][Full Text] [Related]
8. Strong Man with a Weak Heart: The Ill Effects of Performance-Enhancing Drug Use. Ge Y; Liu S; Singh SM Am J Med; 2017 Jan; 130(1):e5-e7. PubMed ID: 27427320 [No Abstract] [Full Text] [Related]
9. Bodybuilding supplements leading to copper toxicity, encephalopathy, fulminant hepatic failure and rhabdomyolysis. Richards JR; Scheerlinck PH; Owen KP; Colby DK Am J Emerg Med; 2020 Nov; 38(11):2487.e1-2487.e5. PubMed ID: 32532617 [TBL] [Abstract][Full Text] [Related]
11. Exogenous Testosterone Abuse and Myocardial Infarction in a Young Bodybuilder. Tan BE; Chowdhury M; Hall C; Baibhav B Am J Med; 2020 Nov; 133(11):e665-e666. PubMed ID: 32416180 [No Abstract] [Full Text] [Related]
12. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Pope HG; Wood RI; Rogol A; Nyberg F; Bowers L; Bhasin S Endocr Rev; 2014 Jun; 35(3):341-75. PubMed ID: 24423981 [TBL] [Abstract][Full Text] [Related]
14. Dilated cardiomyopathy associated with toluene abuse. Vural M; Ogel K Cardiology; 2006; 105(3):158-61. PubMed ID: 16479101 [TBL] [Abstract][Full Text] [Related]
15. Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: A case report and critical review of the literature. Christou GA; Christou KA; Nikas DN; Goudevenos JA Eur J Prev Cardiol; 2016 Nov; 23(16):1785-1796. PubMed ID: 27184497 [TBL] [Abstract][Full Text] [Related]